SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001062993-20-001914
Filing Date
2020-04-23
Accepted
2020-04-23 16:48:55
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM F-3 formf3.htm F-3 197107
2 EXHIBIT 5.1 exhibit5-1.htm EX-5.1 14539
3 EXHIBIT 23.1 exhibit23-1.htm EX-23.1 2148
4 GRAPHIC formf3x001.jpg GRAPHIC 8586
  Complete submission text file 0001062993-20-001914.txt   226706
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-237810 | Film No.: 20811636
SIC: 2834 Pharmaceutical Preparations